BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Bayer AG (BAYN.DE) Patent on Yaz Birth Control Pill Ruled Invalid


4/18/2013 8:03:16 AM

Bayer AG (BAYN)’s patent on the birth control pill Yaz is invalid, a U.S. appeals court said in a decision that ensures Actavis Inc. (ACT) and Novartis AG (NOVN)’s Sandoz unit can sell copies of the contraceptive. Actavis, Sandoz and Lupin Ltd. (LPC) won a ruling that the patent is invalid because it’s an obvious variation of earlier know- how, the U.S. Court of Appeals for the Federal Circuit in Washington said in an opinion posted today on its website. The court overturned a trial judge’s decision to uphold the patent, which expires in June 2014. U.S. sales of branded and generic Yaz were about $347 million in the 12 months ended Feb. 28, according to Actavis, which said in a statement today it began sales of its own version because of the court ruling.

Read at BusinessWeek
Read at Reuters
Read at Wall Street Journal


Bayer AG
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->